about
Safety, immunogenicity and preliminary efficacy of multiple-site vaccination with an Epidermal Growth Factor (EGF) based cancer vaccine in advanced non small cell lung cancer (NSCLC) patientsPhase IIb randomized trial of adjunct immunotherapy in patients with first-diagnosed tuberculosis, relapsed and multi-drug-resistant (MDR) TBIMP321 (sLAG-3), an immunopotentiator for T cell responses against a HBsAg antigen in healthy adults: a single blind randomised controlled phase I studyAntigenized antibodies expressing Vbeta8.2 TCR peptides immunize against rat experimental allergic encephalomyelitisDendritic cells: In the forefront of immunopathogenesis and vaccine development - A reviewTumor-infiltrating effector cells of alpha-galactosylceramide-induced antitumor immunity in metastatic liver tumorBCG vaccination at three different age groups: response and effectivenessWelcome to the Journal of Immune Based Therapies and Vaccines (JIBTV)Association of the T allele of an intronic single nucleotide polymorphism in the colony stimulating factor 1 receptor with Crohn's disease: a case-control studyDevelopment of a model of focal pneumococcal pneumonia in young ratsEffects of monoclonal anti-PcrV antibody on Pseudomonas aeruginosa-induced acute lung injury in a rat modelA Canadian national survey of attitudes and knowledge regarding preventive vaccinesThe effects of chemotherapeutics on cellular metabolism and consequent immune recognitionCurrent problems of perinatal Chlamydia trachomatis infectionsKinetics and isotype profile of antibody responses in rhesus macaques induced following vaccination with HPV 6, 11, 16 and 18 L1-virus-like particles formulated with or without Merck aluminum adjuvantIdentification of proteases employed by dendritic cells in the processing of protein purified derivative (PPD)Generating neutralizing antibodies, Th1 response and MHC non restricted immunogenicity of HIV-I env and gag peptides in liposomes and ISCOMs with in-built adjuvanticityHuman anti-anthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbedTumor-associated antigens identified by mRNA expression profiling as tumor rejection epitopesThe significance of glucose, insulin and potassium for immunology and oncology: a new model of immunity.Psoriatic arthritis: pathogenesis and novel immunomodulatory approaches to treatmentGranulocyte-macrophage colony-stimulating factor as an immune-based therapy in HIV infection.Rapid construction of a dendritic cell vaccine through physical perturbation and apoptotic malignant T cell loadingMycobacterial immune reconstitution inflammatory syndrome in HIV-1 infection after antiretroviral therapy is associated with deregulated specific T-cell responses: beneficial effect of IL-2 and GM-CSF immunotherapyAn alternative approach to combination vaccines: intradermal administration of isolated components for control of anthrax, botulism, plague and staphylococcal toxic shockThe first influenza pandemic in the new millennium: lessons learned hitherto for current control efforts and overall pandemic preparednessProspects for control of emerging infectious diseases with plasmid DNA vaccines.A novel method to identify and characterise peptide mimotopes of heat shock protein 70-associated antigens.CD40mAb adjuvant induces a rapid antibody response that may be beneficial in post-exposure prophylaxisCpG oligodeoxyribonucleotides protect mice from Burkholderia pseudomallei but not Francisella tularensis Schu S4 aerosols.Assessment of immune response to repeat stimulation with BCG vaccine using in vitro PBMC model.PCEP enhances IgA mucosal immune responses in mice following different immunization routes with influenza virus antigens.Probing local innate immune responses after mucosal immunisationHIV-1 sub-type C chimaeric VLPs boost cellular immune responses in mice.Ex vivo development, expansion and in vivo analysis of a novel lineage of dendritic cells from hematopoietic stem cellsGeneration and characterization of high affinity human monoclonal antibodies that neutralize staphylococcal enterotoxin B.Prior exposure to an attenuated Listeria vaccine does not reduce immunogenicity: pre-clinical assessment of the efficacy of a Listeria vaccine in the induction of immune responses against HIV.Levamizole enhances immune responsiveness to intra-dermal and intra-muscular hepatitis B vaccination in chronic hemodialysis patientsImmunotherapeutic role of Ag85B as an adjunct to antituberculous chemotherapyPhytol-based novel adjuvants in vaccine formulation: 2. Assessment of efficacy in the induction of protective immune responses to lethal bacterial infections in mice.
P1433
Q21245661-586AE260-4138-4B28-85CB-5593B6402A8FQ21245662-BF81016F-179F-4ECE-94E6-8E764DAA625DQ21245663-D44612E1-E87A-4DBF-B5F3-1B0357536EA2Q24791647-C0EABC05-C6A9-48AA-BDC3-1D1A10A23218Q24792153-63BB095D-0AB4-483D-B1EE-B62AFB7398B4Q24793051-EBEC83FF-3E97-47A1-8238-339F097AB23FQ24793402-85E2C2DD-2DA8-4D33-93A5-3061EEB22277Q24794125-4EDD960E-1E5E-4FA8-B354-6D2679B4197EQ24794971-8C391BBA-77E9-47E4-B893-40832ABD903AQ24795480-E5803669-B3C1-4CF6-814B-103977BBF95FQ24797978-1031CF88-EF6D-46E3-846B-10275EB51204Q24798043-EEB34269-9B9E-47CA-A2CC-6053E51AFCE1Q24800960-9D4D3EC4-B39F-46C7-88F0-8DA1BDBF1E02Q24801543-41BF0C46-C702-476B-8320-7E5C4948F5F1Q24802323-63A12D9F-0195-4A29-B690-5B5EED4A5840Q24803671-CF79F83F-8C7F-496B-88D9-E4997D0D4A0BQ24806405-A6AB02E3-8900-4260-89B1-3D595268F5E7Q24806902-C4F6A062-8734-4B36-AD7E-E22209B6DB47Q24806913-ED3820FB-BD0C-45DD-935E-6C073228A436Q24812411-039093C6-5B49-46B9-8F13-0B204DB06CA6Q24813979-41122B0E-113D-4C72-8602-076A03D4044FQ24814373-2714B31B-5B22-4DEB-B64C-F6DCB29BB3DCQ24815134-B9B87C19-0F05-4F38-88EC-D90D0ECB86C3Q24815428-9DE31DCF-DB5A-460E-85FF-66860F30BB53Q27486899-FC79648C-378A-409D-A912-8CFF561E01B6Q30227681-5D309933-9B7F-41A1-A3DF-90CFACBDC2E4Q30380454-A3321F29-DB81-4B22-8CE7-BFBA523ADA80Q33239312-6C1EBDA3-EC5F-4473-98FF-919976888438Q33669280-408BEC69-DC64-43FB-B947-AD626C1CB235Q33698285-AC3FD499-1FE9-4D13-900F-DD77153A25D2Q33933553-8EA99A16-67E0-402D-829B-E160C42C2655Q34116871-EFE553FB-D27D-40E3-998F-6F95E5AC4583Q34154378-213A991D-492C-49EB-B1B8-FAFC74105ECAQ34375565-67F22566-E0A4-43F2-985A-AB69E0BEED76Q34419349-45981B30-5D78-45A0-8B85-6FF85060227FQ34498690-F87B510C-747C-47DE-AF71-F7BED0210740Q34552488-416C4F8A-4D9D-48E7-8873-9F81C69BE873Q34977127-77909F6A-0273-4CBF-8705-441586A55D6BQ35124651-9E2D817C-6D80-4CCE-8BFA-0F22F084898BQ35125351-977D4B69-2FF7-4E21-BDB5-B959D9F106FC
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van BioMed Central
@nl
wissenschaftliche Fachzeitschrift
@de
name
Journal of immune based therapies and vaccines
@ast
Journal of immune based therapies and vaccines
@en
Journal of immune based therapies and vaccines
@es
Journal of immune based therapies and vaccines
@nl
type
label
Journal of immune based therapies and vaccines
@ast
Journal of immune based therapies and vaccines
@en
Journal of immune based therapies and vaccines
@es
Journal of immune based therapies and vaccines
@nl
altLabel
J Immune Based Ther Vaccines
@en
prefLabel
Journal of immune based therapies and vaccines
@ast
Journal of immune based therapies and vaccines
@en
Journal of immune based therapies and vaccines
@es
Journal of immune based therapies and vaccines
@nl
P3181
P1055
P1156
P123
P1277
P1476
Journal of immune based therapies and vaccines
@en